Deficiency of adenosine deaminase 2 (DADA2): updates on the phenotype, genetics, pathogenesis, and treatment

I Meyts, I Aksentijevich - Journal of clinical immunology, 2018 - Springer
Abstract Deficiency of ADA2 (DADA2) is the first molecularly described monogenic vasculitis
syndrome. DADA2 is caused by biallelic hypomorphic mutations in the ADA2 gene that …

The type I interferonopathies

MA Lee-Kirsch - Annual review of medicine, 2017 - annualreviews.org
Type I interferons (IFNs) play a central role in the immune defense against viral infections.
Type I IFN activation is induced by pattern-recognition receptors of the innate immune …

ADA2 deficiency (DADA2) as an unrecognised cause of early onset polyarteritis nodosa and stroke: a multicentre national study

R Caorsi, F Penco, A Grossi, A Insalaco… - Annals of the …, 2017 - ard.bmj.com
Objectives To analyse the prevalence of CECR1 mutations in patients diagnosed with early
onset livedo reticularis and/or haemorrhagic/ischaemic strokes in the context of inflammation …

The genetic landscape of Diamond-Blackfan anemia

JC Ulirsch, JM Verboon, S Kazerounian… - The American Journal of …, 2018 - cell.com
Diamond-Blackfan anemia (DBA) is a rare bone marrow failure disorder that affects 7 out of
1,000,000 live births and has been associated with mutations in components of the …

Novel insights and therapeutic approaches in idiopathic multicentric Castleman disease

DC Fajgenbaum - Blood, The Journal of the American Society …, 2018 - ashpublications.org
Castleman disease (CD) describes a heterogeneous group of hematologic disorders that
share characteristic lymph node histopathology. Patients of all ages present with either a …

Hematopoietic stem cell transplantation rescues the hematological, immunological, and vascular phenotype in DADA2

H Hashem, AR Kumar, I Müller, F Babor… - Blood, The Journal …, 2017 - ashpublications.org
Deficiency of adenosine deaminase 2 (DADA2) is caused by biallelic deleterious mutations
in CECR1. DADA2 results in variable autoinflammation and vasculopathy (recurrent fevers …

Deficiency of adenosine deaminase type 2: a description of phenotype and genotype in fifteen cases

S Nanthapisal, C Murphy, E Omoyinmi… - Arthritis & …, 2016 - Wiley Online Library
Objective To describe the clinical features, genotype, and treatment in a series of subjects
with confirmed adenosine deaminase 2 (ADA2) deficiency. Methods All symptomatic …

Expanding spectrum of DADA2: a review of phenotypes, genetics, pathogenesis and treatment

B Pinto, P Deo, S Sharma, A Syal, A Sharma - Clinical Rheumatology, 2021 - Springer
Deficiency of adenosine deaminase 2 (DADA2) is a monogenic disease caused by biallelic
mutations in ADA2 gene (previously CECR1). The aim of this review was to describe the …

Phenotypic variability in patients with ADA2 deficiency due to identical homozygous R169Q mutations

JM Van Montfrans, EAR Hartman, KPJ Braun… - …, 2016 - academic.oup.com
Objective. To determine the genotype–phenotype association in patients with adenosine
deaminase-2 (ADA2) deficiency due to identical homozygous R169Q mutations in CECR1 …

Hematopoietic cell transplantation cures adenosine deaminase 2 deficiency: report on 30 patients

H Hashem, G Bucciol, S Ozen, S Unal… - Journal of clinical …, 2021 - Springer
Purpose Deficiency of adenosine deaminase 2 (DADA2) is an inherited inborn error of
immunity, characterized by autoinflammation (recurrent fever), vasculopathy (livedo …